Benzodiazepines

Journal of Pain and Symptom Management

Volumn 47, Issue 5, 2014, Pages 955-964

  Howard, Paul ^a   Twycross, Robert ^b   Shuster, John ^c   Mihalyo, Mary ^d   Wilcock, Andrew ^e  

^a Earl Mountbatten Hospice   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c Alive Hospice   (United States)

^d DUQUESNE UNIVERSITY   (United States)

^e NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CENTRAL DEPRESSANT AGENT; KETOCONAZOLE; OPIATE; ANXIOLYTIC AGENT;

ACUTE PSYCHOSIS; AGGRESSION; AGITATION; ALCOHOL WITHDRAWAL; ANXIETY DISORDER; ATAXIA; BEHAVIOR DISORDER; COGNITIVE DEFECT; DEPRESSION; DROWSINESS; DRUG CONTRAINDICATION; DRUG INDICATION; DRUG INDUCED DISEASE; DRUG INTERACTION; DRUG SAFETY; DRUG SUBSTITUTION; DYSPNEA; HICCUP; HUMAN; INSOMNIA; MOTOR DYSFUNCTION; MUSCLE HYPOTONIA; MUSCLE SPASM; MYOCLONUS; NAUSEA AND VOMITING; NEUROPATHIC PAIN; PALLIATIVE THERAPY; PANIC; PRURITUS; PSYCHOMOTOR DISORDER; RESTLESS LEGS SYNDROME; REVIEW; SEIZURE; SIDE EFFECT; SLEEP AROUSAL DISORDER; SLEEP DISORDER; UNSTEADINESS; HOSPICE CARE; PROCEDURES;

ANTI-ANXIETY AGENTS; BENZODIAZEPINES; HOSPICE CARE; HUMANS; PALLIATIVE CARE;

EID: 84899872664     PISSN: 08853924     EISSN: 18736513     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2014.03.001     Document Type: Short Survey

References (91)

1. P. Howard, R. Twycross, and J. Shuster et al. Anti-epileptic drugs J Pain Symptom Manage 42 2011 788 804
2. U. Rudolph, and H. Mohler GABA-based therapeutic approaches: GABAA receptor subtype functions Curr Opin Pharmacol 6 2006 18 23
3. H. Mohler The rise of a new GABA pharmacology Neuropharmacology 60 2011 1042 1049
4. D. Graham, C. Faure, F. Besnard, and S.Z. Langer Pharmacological profile of benzodiazepine site ligands with recombinant GABAA receptor subtypes Eur Neuropsychopharmacol 6 1996 119 125
5. D.B. Pritchett, H. Lüddens, and P.H. Seeburg Type I and type II GABAA-benzodiazepine receptors produced in transfected cells Science 245 1989 1389 1392
6. A.J. Smith, L. Alder, and J. Silk et al. Effect of alpha subunit on allosteric modulation of ion channel function in stably expressed human recombinant gamma-aminobutyric acid(A) receptors determined using (36)Cl ion flux Mol Pharmacol 59 2001 1108 1118
7. S. Kumar, P. Porcu, and D.F. Werner et al. The role of GABA(A) receptors in the acute and chronic effects of ethanol: a decade of progress Psychopharmacology (Berl) 205 2009 529 564
8. E. Sanna, F. Busonero, and G. Talani et al. Comparison of the effects of zaleplon, zolpidem, and triazolam at various GABA(A) receptor subtypes Eur J Pharmacol 451 2002 103 110
9. J. Rihel, and A.F. Schier Sites of action of sleep and wake drugs: insights from model organisms Curr Opin Neurobiol 23 2013 831 840
10. M. Lazarus, J.F. Chen, Y. Urade, and Z.L. Huang Role of the basal ganglia in the control of sleep and wakefulness Curr Opin Neurobiol 23 2013 780 785
11. B.G. Dias, S.B. Banerjee, J.V. Goodman, and K.J. Ressler Towards new approaches to disorders of fear and anxiety Curr Opin Neurobiol 23 2013 346 352
12. G. Caillé, J. Spénard, Y. Lacasse, and J. Brennan Pharmacokinetics of two lorazepam formulations, oral and sublingual, after multiple doses Biopharm Drug Dispos 4 1983 31 42
13. D.J. Greenblatt, M. Divoll, J.S. Harmatz, and R.I. Shader Pharmacokinetic comparison of sublingual lorazepam with intravenous, intramuscular, and oral lorazepam J Pharm Sci 71 1982 248 252
14. J. Spénard, G. Caillé, and C. de Montigny et al. Placebo-controlled comparative study of the anxiolytic activity and of the pharmacokinetics of oral and sublingual lorazepam in generalized anxiety Biopharm Drug Dispos 9 1988 457 464
15. P. Gram-Hansen, and A. Schultz Plasma concentrations following oral and sublingual administration of lorazepam Int J Clin Pharmacol Ther Toxicol 26 1988 323 324
16. J. Riss, J. Cloyd, J. Gates, and S. Collins Benzodiazepines in epilepsy: pharmacology and pharmacokinetics Acta Neurol Scand 118 2008 69 86
17. D.R. Drover Comparative pharmacokinetics and pharmacodynamics of short-acting hypnosedatives: zaleplon, zolpidem and zopiclone Clin Pharmacokinet 43 2004 227 238
18. M. Pecking, F. Montestruc, and P. Marquet et al. Absolute bioavailability of midazolam after subcutaneous administration to healthy volunteers Br J Clin Pharmacol 54 2002 357 362
19. L.J. Scott, K.A. Lyseng-Williamson, and K.P. Garnock-Jones Oromucosal midazolam: a guide to its use in paediatric patients with prolonged acute convulsive seizures CNS Drugs 26 2012 893 897
20. M.T. Beigmohammadi, M. Hanifeh, M.R. Rouini, B. Sheikholeslami, and M. Mojtahedzadeh Pharmacokinetics alterations of midazolam infusion versus bolus administration in mechanically ventilated critically ill patients Iran J Pharm Res 12 2013 483 488
21. NPSA (National Patient Safety Agency). Reducing risk of overdose with midazolam injection in adults. Rapid response report 11. 2008. Available from www.nrls.npsa.nhs.uk/resources/?entryid45=59896.
22. A. Kotlinska-Lemieszek Should midazolam drug-drug interactions be of concern to palliative care physicians? Drug Saf 36 2013 789 790
23. R. Grad Benzodiazepines for insomnia in community-dwelling elderly: a review of benefit and risk J Fam Pract 41 1995 473 481
24. C.E. Mancuso, M.G. Tanzi, and M. Gabay Paradoxical reactions to benzodiazepines: literature review and treatment options Pharmacotherapy 24 2004 1177 1185
25. A.A. Weinbroum, O. Szold, D. Ogorek, and R. Flaishon The midazolam-induced paradox phenomenon is reversible by flumazenil. Epidemiology, patient characteristics and review of the literature Eur J Anaesthesiol 18 2001 789 797
26. T. Saias, and T. Gallarda Paradoxical aggressive reactions to benzodiazepine use: a review [in French] Encephale 34 2008 330 336
27. C.R. Dolder, and M.H. Nelson Hypnosedative-induced complex behaviours: incidence, mechanisms and management CNS Drugs 22 2008 1021 1036
28. S. Billioti de Gage, B. Bégaud, and F. Bazin et al. Benzodiazepine use and risk of dementia: prospective population based study BMJ 345 2012 e6231
29. C. Bocti, J. Roy-Desruisseaux, and P. Roberge Research paper most likely shows that benzodiazpeines are used to treat early symptoms of dementia [Letter] BMJ 345 2012 e7986
30. I.T. Coyle-Gilchrist, L.F. Peck, and J.B. Rowe Research paper does now show casual link between benzodiazepines use and diagnosis of dementia [Letter] BMJ 345 2012 e7984
31. G.K. Isbister, L. O'Regan, D. Sibbritt, and I.M. Whyte Alprazolam is relatively more toxic than other benzodiazepines in overdose Br J Clin Pharmacol 58 2004 88 95
32. C.M. Morin, J.P. Culbert, and S.M. Schwartz Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy Am J Psychiatry 151 1994 1172 1180
33. D.R. Murtagh, and K.M. Greenwood Identifying effective psychological treatments for insomnia: a meta-analysis J Consult Clin Psychol 63 1995 79 89
34. M.T. Smith, M.L. Perlis, and A. Park et al. Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia Am J Psychiatry 159 2002 5 11
35. H. Hugel, J.E. Ellershaw, L. Cook, J. Skinner, and C. Irvine The prevalence, key causes and management of insomnia in palliative care patients J Pain Symptom Manage 27 2004 316 321
36. R. Twycross, A. Wilcock, and C.S. Toller Symptom management in advanced cancer 4th ed. 2009 palliativedrugs.com Nottingham 203 204
37. N. Buscemi, B. Vandermeer, and C. Friesen et al. The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs J Gen Intern Med 22 2007 1335 1350
38. J. Glass, K.L. Lanctôt, N. Herrmann, B.A. Sproule, and U.E. Busto Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits BMJ 331 2005 1169
39. P.S. Wang, R.L. Bohn, R.J. Glynn, H. Mogun, and J. Avorn Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture Am J Psychiatry 158 2001 892 898
40. P. Howard, R. Twycross, J. Shuster, M. Mihalyo, and A. Wilcock Antidepressant drugs J Pain Symptom Manage 44 2012 763 783
41. Melatonin R. Twycross, and A. Wilcock Palliative care formulary 4th ed 2011 palliativedrugs.com Nottingham 148 150
42. S.J. Wilson, D.J. Nutt, and C. Alford et al. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders J Psychopharmacol 24 2010 1577 1601
43. B. Bandelow, U. Seidler-Brandler, A. Becker, D. Wedekind, and E. Rüther Meta-analysis of randomized controlled comparisons of psychopharmacological and psychological treatments for anxiety disorders World J Biol Psychiatry 8 2007 175 187
44. D.S. Baldwin, I.M. Anderson, and D.J. Nutt et al. British Association for Psychopharmacology. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology J Psychopharmacol 19 2005 567 596
45. D. Baldwin Efficacy of drug treatments for generalised anxiety disorder: systematic review and meta-analysis BMJ 342 2011 1199
46. T.A. Furukawa, D.L. Streiner, and L.T. Young Antidepressant plus benzodiazepine for major depression Cochrane Database Syst Rev 2001 CD001026
47. S. Foster, J. Kessel, M.E. Berman, and G.M. Simpson Efficacy of lorazepam and haloperidol for rapid tranquilization in the psychiatric emergency room setting Int Clin Psychopharmacol 12 1997 175 179
48. S.T. Simon, I.J. Higginson, S. Booth, R. Harding, and C. Bausewein Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults Cochrane Database Syst Rev 2010 CD007354
49. A.H. Navigante, L.C. Cerchietti, M.A. Castro, M.A. Lutteral, and M.E. Cabalar Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer J Pain Symptom Manage 31 2006 38 47
50. E. Rey, J.M. Tréluyer, and G. Pons Pharmacokinetic optimization of benzodiazepines therapy for acute seizures. Focus on delivery routes Clin Pharmacokinet 36 1999 409 424
51. British National Formulary Section 4.8.2 Drugs used in status epilepticus British National Formulary (No. 61) 2013 British Medical Association and Royal Pharmaceutical Society of Great Britain London Current BNF available from www.bnf.org
52. J. McIntyre, S. Robertson, and E. Norris et al. Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial Lancet 366 2005 205 210
53. R. Twycross, and A. Wilcock Phenobarbital Palliative care formulary 4th ed 2011 palliativedrugs.com Nottingham 270 274
54. R. Twycross, and A. Wilcock Valproate Palliative care formulary 4th ed 2011 palliativedrugs.com Nottingham 264 268
55. J.M. López-Saca, J. Vaquero, A. Larumbe, J. Urdíroz, and C. Centeno Repeated use of subcutaneous levetiracetam in a palliative care patient [Letter] J Pain Symptom Manage 45 2013 e7 e8
56. R.N. Aurora, D.A. Kristo, and S.R. Bista et al. The treatment of restless legs syndrome and periodic limb movement disorder in adults-an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice Guideline Sleep 35 2012 1039 1062
57. D. Garcia-Borreguero, L. Ferini-Strambi, and R. Kohnen et al. European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society Eur J Neurol 19 2012 1385 1396
58. R. Twycross, and A. Wilcock Drug-induced movement disorders Palliative care formulary 4th ed 2011 palliativedrugs.com Nottingham 745 749
59. A.R. Lima, K. Soares-Weiser, J. Bacaltchuk, and T.R. Barnes Benzodiazepines for neuroleptic-induced acute akathisia Cochrane Database Syst Rev 2002 CD001950
60. D. Gagrat, J. Hamilton, and R.H. Belmaker Intravenous diazepam in the treatment of neuroleptic-induced acute dystonia and akathisia Am J Psychiatry 135 1978 1232 1233
61. P.S. Bhoopathi, and K. Soares-Weiser Benzodiazepines for neuroleptic-induced tardive dyskinesia Cochrane Database Syst Rev 2006 CD000205
62. H. Hugel, J.E. Ellershaw, and A. Dickman Clonazepam as an adjuvant analgesic in patients with cancer-related neuropathic pain J Pain Symptom Manage 26 2003 1073 1074
63. S.L. Bartusch, B.J. Sanders, J.G. D'Alessio, and J.R. Jernigan Clonazepam for the treatment of lancinating phantom limb pain Clin J Pain 12 1996 59 62
64. A.J. Bouckoms, and R.E. Litman Clonazepam in the treatment of neuralgic pain syndrome Psychosomatics 26 1985 933 936
65. M. Swerdlow, and J. Cundill Anticonvulsant drugs used in the treatment of lancinating pain: a comparison Anaesthesia 36 1981 1129 1132
66. P.H. Vuilleumier, M. Besson, J. Desmeules, L. Arendt-Nielsen, and M. Curatolo Evaluation of anti-hyperalgesic and analgesic effects of two benzodiazepines in human experimental pain: a randomized placebo-controlled study PLoS One 8 2013 e43896
67. R. Corrigan, S. Derry, P.J. Wiffen, and R.A. Moore Clonazepam for neuropathic pain and fibromyalgia in adults Cochrane Database Syst Rev 2012 CD009486
68. R. Chou, and L.H. Huffman Medications for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline Ann Intern Med 147 2007 505 514
69. D.T. Shakespeare, M. Boggild, and C. Young Anti-spasticity agents for multiple sclerosis Cochrane Database Syst Rev 2003 CD001332
70. M. Taricco, R. Adone, C. Pagliacci, and E. Telaro Pharmacological interventions for spasticity following spinal cord injury Cochrane Database Syst Rev 2000 CD001131
71. J.F. Bishop, I.N. Olver, and M.M. Wolf et al. Lorazepam: a randomized, double-blind, crossover study of a new antiemetic in patients receiving cytotoxic chemotherapy and prochlorperazine J Clin Oncol 2 1984 691 695
72. D. Razavi, N. Delvaux, and C. Farvacques et al. Prevention of adjustment disorders and anticipatory nausea secondary to adjuvant chemotherapy: a double-blind, placebo-controlled study assessing the usefulness of alprazolam J Clin Oncol 11 1993 1384 1390
73. I.A. Malik, W.A. Khan, and M. Qazilbash et al. Clinical efficacy of lorazepam in prophylaxis of anticipatory, acute, and delayed nausea and vomiting induced by high doses of cisplatin. A prospective randomized trial Am J Clin Oncol 18 1995 170 175
74. T. Di Florio, and C.R. Goucke The effect of midazolam on persistent postoperative nausea and vomiting Anaesth Intensive Care 27 1999 38 40
75. M. Mandalà, M. Cremonesi, and A. Rocca et al. Midazolam for acute emesis refractory to dexamethasone and granisetron after highly emetogenic chemotherapy: a phase II study Support Care Cancer 13 2005 375 380
76. M.S. Aapro, A. Molassiotis, and I. Olver Anticipatory nausea and vomiting Support Care Cancer 13 2005 117 121
77. L. Amato, S. Minozzi, S. Vecchi, and M. Davoli Benzodiazepines for alcohol withdrawal Cochrane Database Syst Rev 2010 CD005063
78. M.P. Peppers Benzodiazepines for alcohol withdrawal in the elderly and in patients with liver disease Pharmacotherapy 16 1996 49 57
79. J. Chick Review: benzodiazepines are more effective than neuroleptics in reducing delirium and seizures in alcohol withdrawal Evid Based Ment Health 3 1998 11
80. O. Hägermark Influence of antihistamines, sedatives, and aspirin on experimental itch Acta Derm Venereol 53 1973 363 368
81. H. Muston, R. Felix, and S. Shuster Differential effect of hypnotics and anxiolytics on itch and scratch J Invest Dermatol 72 1979 283
82. T. Ebata, H. Izumi, H. Aizawa, R. Kamide, and M. Niimura Effects of nitrazepam on nocturnal scratching in adults with atopic dermatitis: a double-blind placebo-controlled crossover study Br J Dermatol 138 1998 631 634
83. R. Twycross, M.W. Greaves, and H. Handwerker et al. Itch: scratching more than the surface QJM 96 2003 7 26
84. C. Moro, P. Sironi, E. Berardi, G. Beretta, and R. Labianca Midazolam for long-term treatment of intractable hiccup [Letter] J Pain Symptom Manage 29 2005 221 223
85. A. Wilcock, and R. Twycross Midazolam for intractable hiccup J Pain Symptom Manage 12 1996 59 61
86. J.G. Whitwam, D. Al-Khudhairi, and R.F. McCloy Comparison of midazolam and diazepam in doses of comparable potency during gastroscopy Br J Anaesth 55 1983 773 777
87. S.G. Cole, S. Brozinsky, and J.I. Isenberg Midazolam, a new more potent benzodiazepine, compared with diazepam: a randomized, double-blind study of preendoscopic sedatives Gastrointest Endosc 29 1983 219 222
88. British National Formulary Section 4.1. Hypnotics and anxiolytics British National Formulary (No. 61) 2013 British Medical Association and Royal Pharmaceutical Society of Great Britain London Current BNF available from www.bnf.org
89. American Society of Health-System Pharmacists (AHFS). Benzodiazepines general statement (pharmacokinetics). AHFS Drug Information 2009 (online edition). Available from www.ahfsdruginformation.com/ (subscription required).
90. D. Taylor, C. Paton, and S. Kapur Benzodiazepines: dependence and detoxification. In: The Maudsley prescribing guidelines in psychiatry 11th ed 2012 Wiley-Blackwell Chichester 307 308
91. S. Bazire Psychotropic drug directory 2012 Lloyd-Reinhold Communications LLP Cheltenham 211